Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

VBIOValion Bio, Inc.

Nasdaq · CIK 0001787740
Filer category<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts309

Identity from submissions API

NameValion Bio, Inc.
CIK0001787740
TickersVBIO
ExchangesNasdaq
Entity typeoperating
Category<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN814016391
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(888)276-6888
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Tivic Health Systems, Inc. (2019-09-10T04:00:00.000Z → 2026-04-23T04:00:00.000Z)
Business address
1305 E. HOUSTON STREET
BUILDING 1, SUITE 311
SAN ANTONIO
TX
78205
TX
Mailing address
1305 E. HOUSTON STREET
BUILDING 1, SUITE 311
SAN ANTONIO
TX
78205
TX

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

407 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 8-K FORM 8-K 5.02,5.07 0001683168-26-008851 001-41052 261560971 34 198141 1 1
2026-11-16 NT 10-Q 10-Q EXTENSION FOR SEP 2026 0001683168-26-008846 001-41052 261560436 34 22221
2026-11-12 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-126218 005-93529 261546821 34 18902
2026-11-09 8-K CURRENT REPORT 1.01,3.02,9.01 0001683168-26-008390 001-41052 261533604 34 226730 1 1
2026-11-05 8-K FORM 8-K 5.02 0001683168-26-008352 001-41052 261527573 34 191182 1 1
2026-11-02 8-K FORM 8-K 5.02,8.01,9.01 0001683168-26-008221 001-41052 261509915 34 303786 1 1
2026-10-29 8-K FORM 8-K 8.01,9.01 0001437749-26-033850 001-41052 261497554 34 187653 1 1
2026-10-27 8-K FORM 8-K 1.01,3.02,9.01 0001437749-26-033552 001-41052 261487211 34 214277 1 1
2026-10-26 8-K FORM 8-K 8.01,9.01 0001437749-26-033460 001-41052 261483563 34 181790 1 1
2026-10-22 8-K FORM 8-K 8.01,9.01 0001437749-26-033175 001-41052 261477255 34 196715 1 1
2026-10-21 424B3 424B3 0001683168-26-007998 333-299506 261473834 33 218516
2026-10-20 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-003301 333-299355 261474060 33 1880
2026-10-20 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-003309 333-299506 261474054 33 1880
2026-10-16 S-3 REGISTRATION STATEMENT 0001683168-26-007936 333-299506 261467058 33 735977 1 1
2026-10-16 DEF 14A DEFINITIVE PROXY STATEMENT 0001683168-26-007932 001-41052 261466693 34 605486
2026-10-15 8-K CURRENT REPORT 8.01,9.01 0001683168-26-007857 001-41052 261461363 34 226831 1 1
2026-10-14 8-K CURRENT REPORT 8.01,9.01 0001683168-26-007834 001-41052 261458343 34 213350 1 1
2026-10-08 8-K CURRENT REPORT 1.01,3.02,9.01 0001683168-26-007709 001-41052 261448156 34 222960 1 1
2026-10-08 S-3 REGISTRATION STATEMENT 0001683168-26-007707 333-299355 261448043 33 4117528 1 1
2026-10-06 8-K FORM 8-K 8.01,9.01 0001437749-26-032107 001-41052 261442311 34 182067 1 1
2026-10-05 DRS filename1.htm 0001683168-26-007617 377-09838 261440585 33 344516
2026-10-02 PRE 14A PRELIMINARY PROXY STATEMENT 0001683168-26-007588 001-41052 261439108 34 1069143
2026-10-01 8-K CURRENT REPORT 8.01,9.01 0001683168-26-007514 001-41052 261428953 34 229501 1 1
2026-09-24 4 xslF345X06/ownership.xml 0001683168-26-007398 5989
2026-09-24 4 xslF345X06/ownership.xml 0001683168-26-007396 9756
2026-09-23 8-K FORM 8-K 5.02,7.01,9.01 0001683168-26-007300 001-41052 261398210 34 318975 1 1
2026-09-17 3 xslF345X06/ownership.xml 0001683168-26-007217 15740
2026-09-17 3 xslF345X06/ownership.xml 0001683168-26-007216 14982
2026-09-04 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001753926-26-001726 005-93529 261363158 34 19753
2026-09-03 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001753926-26-001719 005-93529 261359921 34 18600
2026-09-02 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001753926-26-001702 005-93529 261356473 34 20900
2026-09-01 8-K FORM 8-K 1.01,3.02,5.02,7.01,9.01 0001683168-26-006848 001-41052 261348390 34 271462 1 1
2026-08-27 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001753926-26-001647 005-93529 261332525 34 18999
2026-08-27 8-K CURRENT REPORT 3.03,5.03,7.01,9.01 0001683168-26-006742 001-41052 261325284 34 244147 1 1
2026-08-24 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001753926-26-001610 005-93529 261312069 34 28607
2026-08-24 RW REGISTRATION WITHDRAWAL REQUEST 0001683168-26-006676 333-297529 261306260 NE 12842
2026-08-20 8-K/A AMENDMENT NO 1 5.07 0001683168-26-006632 001-41052 261300046 34 199863 1 1
2026-08-19 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001753926-26-001562 005-93529 261297038 34 28110
2026-08-17 8-K CURRENT REPORT 3.02,5.02,5.07,8.01,9.01 0001683168-26-006501 001-41052 261284649 34 523257 1 1
2026-08-14 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001753926-26-001528 005-93529 261284299 34 31129
2026-08-14 10-Q FORM 10-Q 0001437749-26-028069 001-41052 261283930 34 11406054 1 1
2026-08-12 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002641 333-297529 261269685 33 1880
2026-08-11 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001753926-26-001421 005-93529 261263132 34 42587
2026-08-06 8-K CURRENT REPORT 1.01,3.02,8.01 0001683168-26-006049 001-41052 261248899 34 212705 1 1
2026-08-03 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001753926-26-001299 005-93529 261230425 34 127589
2026-07-17 DEF 14A DEFINITIVE PROXY STATEMENT 0001683168-26-005615 001-41052 261184119 34 1432937
2026-07-17 S-1 DRAFT REGISTRATION STATEMENT 0001683168-26-005613 333-297529 261183696 33 1650002 1 1
2026-07-17 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001838556-26-000012 005-93529 261182209 34 33618
2026-07-14 8-K CURRENT REPORT 7.01,9.01 0001683168-26-005497 001-41052 261172548 34 241129 1 1
2026-07-07 PRE 14A PRELIMINARY PROXY 0001683168-26-005335 001-41052 261160050 34 1429997
2026-06-18 4 xslF345X06/ownership.xml 0001683168-26-004970 7641
2026-06-18 8-K CURRENT REPORT 3.02,8.01 0001683168-26-004956 001-41052 261100614 34 193233 1 1
2026-06-05 S-8 FORM S-8 0001683168-26-004591 333-296561 261069975 33 382573 1 1
2026-06-05 S-8 FORM S-8 0001683168-26-004589 333-296558 261069965 33 292935 1 1
2026-06-03 8-K CURRENT REPORT 5.02,5.07,9.01 0001683168-26-004481 001-41052 261059136 34 226892 1 1
2026-05-20 4 xslF345X06/ownership.xml 0001683168-26-004192 7680
2026-05-14 10-Q FORM 10-Q 0001437749-26-017142 001-41052 26980658 34 9996290 1 1
2026-05-14 8-K FORM 8-K 2.02,7.01,9.01 0001437749-26-017082 001-41052 26979739 34 282837 1 1
2026-05-08 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001753926-26-000801 005-93529 26959532 34 20237
2026-05-04 4 xslF345X06/ownership.xml 0001683168-26-003448 5972
2026-05-04 3 xslF345X06/ownership.xml 0001683168-26-003447 14802
2026-05-04 8-K FORM 8-K 5.02,7.01,9.01 0001683168-26-003446 001-41052 26937467 34 315533 1 1
2026-04-30 ARS ANNUAL REPORT 0001683168-26-003337 001-41052 26920254 34 1482579
2026-04-30 DEF 14A DEFINITIVE PROXY STATEMENT 0001683168-26-003334 001-41052 26920237 34 1471203
2026-04-23 8-K CURRENT REPORT 5.03,9.01 0001683168-26-003161 001-41052 26889204 34 229458 1 1
2026-04-20 PRE 14A PRELIMINARY PROXY STATEMENT 0001683168-26-003076 001-41052 26875130 34 954507
2026-04-20 4 xslF345X06/ownership.xml 0001683168-26-003073 4706
2026-04-15 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001207 333-295029 26865548 33 1807
2026-04-15 424B3 PROSPECTUS 0001683168-26-003004 333-295029 26864875 33 200746
2026-04-13 CORRESP filename1.htm 0001683168-26-002870 7267
2026-04-13 DRS filename1.htm 0001683168-26-002868 377-09252 26858497 33 466028
2026-04-13 S-1 FORM S-1 0001683168-26-002867 333-295029 26858488 33 810516 1 1
2026-04-09 UPLOAD filename1.pdf 0000000000-26-003598 377-09227 40632
2026-04-06 DRS filename1.htm 0001683168-26-002695 377-09227 26842140 33 353849
2026-04-02 4 xslF345X06/ownership.xml 0001683168-26-002599 4697
2026-03-30 10-K FORM 10-K 0001437749-26-010343 001-41052 26813601 34 14210499 1 1
2026-03-25 8-K FORM 8-K 2.02,7.01,9.01 0001437749-26-009789 001-41052 26792807 34 212681 1 1
2026-03-20 8-K FORM 8-K 3.01 0001683168-26-002064 001-41052 26779156 34 194303 1 1
2026-03-19 4 xslF345X06/ownership.xml 0001683168-26-002034 7816
2026-03-13 8-K CURRENT REPORT 1.01,9.01 0001683168-26-001781 001-41052 26753618 34 904501 1 1
2026-03-11 8-K FORM 8-K 5.07,8.01 0001683168-26-001687 001-41052 26744451 34 192715 1 1
2026-03-04 8-K CURRENT REPORT 5.02,7.01,9.01 0001683168-26-001461 001-41052 26718945 34 310403 1 1
2026-02-27 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001753926-26-000402 005-93529 26699596 34 27029
2026-02-23 8-K/A FORM 8-K AMENDMENT 9.01 0001683168-26-001263 001-41052 26666447 34 1697035 1 1
2026-02-20 4 xslF345X05/ownership.xml 0001683168-26-001220 7356
2026-02-09 DEFA14A FORM DEFA 14A 0001683168-26-000878 001-41052 26612147 34 1532288
2026-02-09 8-K FORM 8-K 1.01,3.02,9.01 0001683168-26-000877 001-41052 26612137 34 1176675 1 1
2026-01-20 424B3 PROSPECTUS 0001683168-26-000421 333-292467 26542866 33 200910
2026-01-20 424B3 PROSPECTUS 0001683168-26-000420 333-292468 26542865 33 231445
2026-01-20 8-K CURRENT REPORT 7.01,9.01 0001683168-26-000398 001-41052 26541272 34 4125868 1 1
2026-01-16 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000200 333-292468 26540917 33 1753
2026-01-16 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000199 333-292467 26540916 33 1753
2026-01-14 CORRESP filename1.htm 0001683168-26-000313 6986
2026-01-14 CORRESP filename1.htm 0001683168-26-000312 6919
2026-01-09 DEF 14A DEF 14A 0001683168-26-000194 001-41052 26523431 34 555832
2026-01-05 UPLOAD filename1.pdf 0000000000-26-000086 333-292467 40333
2026-01-05 UPLOAD filename1.pdf 0000000000-26-000085 333-292468 40337
2025-12-29 D xslFormDX01/primary_doc.xml 06b 0001683168-25-009395 021-568271 251610060 33 9511
2025-12-29 D xslFormDX01/primary_doc.xml 06b 0001683168-25-009394 021-568269 251610042 33 9518
2025-12-29 PRE 14A PRELIMINARY PROXY STATEMENT 0001683168-25-009392 001-41052 251610036 34 258623
2025-12-29 S-3 FORM S-3 REGISTRATION STATEMENT 0001683168-25-009390 333-292468 251610007 33 489266 1 1
2025-12-29 S-3 FORM S-3 REGISTRATION STATEMENT 0001683168-25-009388 333-292467 251609977 33 517486 1 1
2025-12-22 4 xslF345X05/ownership.xml 0001683168-25-009306 9170
2025-12-22 4 xslF345X05/ownership.xml 0001683168-25-009305 9180
2025-12-12 424B3 PROSPECTUS 0001683168-25-009089 333-290944 251566711 33 43529
2025-12-12 424B3 PROSPECTUS 0001683168-25-009087 333-289953 251566705 33 43390
2025-12-11 8-K CURRENT REPORT 1.01,1.02,2.01,2.03,3.02,3.03,5.03,7.01,9.01 0001683168-25-009079 001-41052 251565718 34 13522046 1 1
2025-11-18 8-K FORM 8-K 8.01,9.01 0001437749-25-035521 001-41052 251492910 34 184819 1 1
2025-11-14 10-Q FORM 10-Q 0001437749-25-035216 001-41052 251487286 34 8854068 1 1
2025-11-14 8-K FORM 8-K 2.02,2.05,7.01,9.01 0001437749-25-035208 001-41052 251487168 34 296521 1 1
2025-11-13 8-K 8-K 8.01,9.01 0001683168-25-008287 001-41052 251475590 34 219677 1 1
2025-11-06 424B3 FORM 424B3 0001683168-25-008037 333-290944 251459377 33 236082
2025-10-17 S-3 REGISTRATION STATEMENT 0001683168-25-007643 333-290944 251401440 33 558906 1 1
2025-10-15 8-K FORM 8-K 5.02,9.01 0001437749-25-031054 001-41052 251395429 34 234903 1 1
2025-09-24 4 xslF345X05/ownership.xml 0001683168-25-007223 4520
2025-09-17 1-A-W OFFERING STATEMENT WITHDRAWAL 0001683168-25-007072 024-12489 251320398 33 6763
2025-09-05 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002853 333-289953 251298407 33 1754
2025-09-05 424B3 424B3 0001683168-25-006729 333-289953 251297408 33 222771
2025-09-03 CORRESP filename1.htm 0001683168-25-006660 7061
2025-09-03 UPLOAD filename1.pdf 0000000000-25-009477 333-289953 40213
2025-08-29 S-3 REGISTRATION STATEMENT 0001683168-25-006582 333-289953 251281807 33 544875 1 1
2025-08-27 8-K 8-K 8.01 0000950170-25-111709 001-41052 251265341 34 146434 1 1
2025-08-22 4/A xslF345X05/ownership.xml 0001683168-25-006430 6036
2025-08-22 4/A xslF345X05/ownership.xml 0001683168-25-006429 6021
2025-08-22 4/A xslF345X05/ownership.xml 0001683168-25-006428 6012
2025-08-20 8-K 8-K 8.01,9.01 0000950170-25-110374 001-41052 251234000 34 201964 1 1
2025-08-14 10-Q 10-Q 0000950170-25-108977 001-41052 251220031 34 11368902 1 1
2025-08-14 8-K 8-K 2.02,7.01,9.01 0000950170-25-108835 001-41052 251218520 34 378217 1 1
2025-08-12 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002590 333-289441 251208765 33 1754
2025-08-12 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002589 333-289436 251208764 33 1754
2025-08-12 424B3 PROSPECTUS 0001683168-25-005988 333-289441 251208028 33 233093
2025-08-12 424B3 PROSPECTUS 0001683168-25-005987 333-289436 251208002 33 207485
2025-08-08 4 xslF345X05/ownership.xml 0001683168-25-005837 5484
2025-08-08 4 xslF345X05/ownership.xml 0001683168-25-005836 5633
2025-08-08 4 xslF345X05/ownership.xml 0001683168-25-005835 5476
2025-08-08 4 xslF345X05/ownership.xml 0001683168-25-005834 5618
2025-08-08 4 xslF345X05/ownership.xml 0001683168-25-005833 5609
2025-08-08 4 xslF345X05/ownership.xml 0001683168-25-005832 5447
2025-08-08 CORRESP filename1.htm 0001683168-25-005815 6799
2025-08-08 CORRESP filename1.htm 0001683168-25-005813 6890
2025-08-08 S-3 S-3 0001683168-25-005809 333-289441 251199033 33 504552 1 1
2025-08-08 S-3 FORM S-3 0001683168-25-005807 333-289436 251198944 33 522796 1 1
2025-08-05 UPLOAD filename1.pdf 0000000000-25-008243 377-08288 40386
2025-08-04 DRS filename1.htm 0001683168-25-005636 377-08288 251180983 33 280084
2025-08-04 DRSLTR filename1.htm 0001683168-25-005635 15164
2025-07-31 UPLOAD filename1.pdf 0000000000-25-008071 377-08260 40406
2025-07-30 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002408 333-287853 251169099 33 1754
2025-07-30 424B3 PROSPECTUS 0001683168-25-005528 333-287853 251168133 33 191391
2025-07-28 CORRESP filename1.htm 0001683168-25-005446 7326
2025-07-25 CORRESP filename1.htm 0001683168-25-005422 21420
2025-07-25 S-1/A AMENDMENT #1 TO FORM S-1 0001683168-25-005421 333-287853 251152313 33 776404 1 1
2025-07-25 S-8 INITIAL REGISTRATION STATEMENT 0001683168-25-005419 333-288969 251152242 33 180904
2025-07-25 S-8 INITIAL REGISTRATION STATEMENT 0001683168-25-005418 333-288968 251152234 33 159484
2025-07-25 DRS filename1.htm 0001683168-25-005416 377-08260 251152173 33 312672
2025-07-25 8-K/A 8-K/A 1.01,9.01 0000950170-25-098773 001-41052 251151654 34 538510 1 1
2025-07-09 UPLOAD filename1.pdf 0000000000-25-007241 377-08017 44396
2025-07-07 8-K 8-K 5.02,5.07,9.01 0000950170-25-094222 001-41052 251108129 34 361250 1 1
2025-06-26 CORRESP filename1.htm 0001683168-25-004777 26729
2025-06-25 8-K 8-K 1.01,9.01 0000950170-25-089981 001-41052 251074007 34 527010 1 1
2025-06-25 8-K 8-K 7.01,9.01 0000950170-25-089741 001-41052 251071106 34 208104 1 1
2025-06-17 UPLOAD filename1.pdf 0000000000-25-006369 377-08017 44542
2025-06-06 CORRESP filename1.htm 0001683168-25-004308 55271
2025-06-06 S-1 FORM S-1 0001683168-25-004306 333-287853 251031267 33 603044 1 1
2025-06-02 ARS FORM ARS 0001683168-25-004154 001-41052 251015569 34 755806
2025-06-02 DEF 14A DEFINITIVE PROXY STMT 0001683168-25-004153 001-41052 251015409 34 1020734
2025-05-23 PRE 14A FORM PRE 14A 0001683168-25-003999 001-41052 25982961 34 1021281
2025-05-22 8-K 8-K 7.01,9.01 0000950170-25-076060 001-41052 25974806 34 10593942 1 1
2025-05-21 UPLOAD filename1.pdf 0000000000-25-005416 377-08017 44179
2025-05-20 8-K 8-K 5.08,8.01 0000950170-25-075301 001-41052 25969583 34 151584 1 1
2025-05-15 DRS filename1.htm 0001683168-25-003732 377-08017 25955052 33 304281
2025-05-15 DRSLTR filename1.htm 0001683168-25-003731 13146
2025-05-15 10-Q 10-Q 0000950170-25-072752 001-41052 25954176 34 10847967 1 1
2025-05-15 8-K 8-K 2.02,7.01,9.01 0000950170-25-072603 001-41052 25952782 34 357717 1 1
2025-05-14 8-K 8-K 1.01,7.01,9.01 0000950170-25-070948 001-41052 25942777 34 224687 1 1
2025-05-13 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001569 333-287157 25942403 33 1753
2025-05-13 424B3 424B3 0001683168-25-003498 333-287157 25941207 33 180601
2025-05-09 CORRESP filename1.htm 0001683168-25-003360 8006
2025-05-09 S-1 DRAFT REGISTRATION STATEMENT 0001683168-25-003353 333-287157 25930735 33 657066 1 1
2025-05-08 UPLOAD filename1.pdf 0000000000-25-004915 377-07973 40453
2025-05-02 DRS filename1.htm 0001683168-25-003085 377-07973 25909009 33 319248
2025-05-02 DRSLTR filename1.htm 0001683168-25-003083 41019
2025-05-02 8-K 8-K 1.01,3.02,3.03,5.03,9.01 0000950170-25-062733 001-41052 25908353 34 1355209 1 1
2025-04-22 8-K 8-K 8.01,9.01 0000950170-25-056480 001-41052 25855605 34 216734 1 1
2025-04-14 8-K 8-K 8.01,9.01 0000950170-25-053769 001-41052 25836643 34 545150 1 1
2025-04-14 424B5 FORM 424B5 0001683168-25-002545 333-269494 25836629 33 50769
2025-04-10 8-K 8-K 7.01,8.01,9.01 0000950170-25-052679 001-41052 25826585 34 202404 1 1
2025-04-03 8-K 8-K 3.02,8.01 0000950170-25-050485 001-41052 25810088 34 172389 1 1
2025-03-21 10-K 10-K 0000950170-25-043234 001-41052 25760875 34 13146673 1 1
2025-03-21 8-K 8-K 1.01,2.02,3.02,7.01,9.01 0000950170-25-043166 001-41052 25760370 34 8296079 1 1
2025-03-06 8-K 8-K 8.01,9.01 0000950170-25-034191 001-41052 25713684 34 215009 1 1
2025-03-05 8-K 8-K 3.03,5.03,7.01,9.01 0000950170-25-033091 001-41052 25708939 34 267188 1 1
2025-02-24 4 xslF345X05/ownership.xml 0001683168-25-001207 6189
2025-02-24 3 xslF345X02/ownership.xml 0001683168-25-001206 15299
2025-02-24 8-K 8-K 5.02,7.01,9.01 0000950170-25-025238 001-41052 25654307 34 351598 1 1
2025-02-12 8-K 8-K 1.01,3.02,5.03,7.01,9.01 0000950170-25-018419 001-41052 25612132 34 1191072 1 1
2025-02-05 8-K 8-K 5.07 0000950170-25-014601 001-41052 25594042 34 169355 1 1
2025-01-03 DEF 14A DEFINITIVE PROXY 0001683168-25-000065 001-41052 25506359 34 584720
2025-01-03 8-K 8-K 3.01 0000950170-25-001140 001-41052 25505949 34 155872 1 1
2024-12-23 8-K CURRENT REPORT 7.01,9.01 0001683168-24-008948 001-41052 241574498 34 236366 1 1
2024-12-23 PRE 14A PRELIMINARY PROXY STATEMENT 0001683168-24-008946 001-41052 241574239 34 584080
2024-12-20 4 xslF345X05/ownership.xml 0001683168-24-008902 5577
2024-12-20 4 xslF345X05/ownership.xml 0001683168-24-008901 5816
2024-12-20 4 xslF345X05/ownership.xml 0001683168-24-008900 5799
2024-12-20 4 xslF345X05/ownership.xml 0001683168-24-008899 5808
2024-12-20 4 xslF345X05/ownership.xml 0001683168-24-008898 5537
2024-12-20 4 xslF345X05/ownership.xml 0001683168-24-008897 5569
2024-12-13 1-A/A xsl1-A_X01/primary_doc.xml 0001683168-24-008698 024-12489 241548169 33 1870983
2024-11-14 10-Q 10-Q 0000950170-24-127072 001-41052 241462418 34 7483710 1 1
2024-11-14 8-K 8-K 2.02,7.01 0000950170-24-127045 001-41052 241462049 34 328022 1 1
2024-11-07 1-A/A xsl1-A_X01/primary_doc.xml 0001683168-24-007747 024-12489 241435959 33 1880860
2024-10-04 1-A/A xsl1-A_X01/primary_doc.xml 0001683168-24-006944 024-12489 241354916 33 1884298
2024-10-03 4 xslF345X05/ownership.xml 0001683168-24-006909 3413
2024-10-03 4 xslF345X05/ownership.xml 0001683168-24-006907 3393
2024-10-03 3 xslF345X02/ownership.xml 0001683168-24-006905 10722
2024-09-18 8-K 8-K 8.01,9.01 0000950170-24-107614 001-41052 241306272 34 194970 1 1
2024-09-17 8-K 8-K 8.01,9.01 0000950170-24-107032 001-41052 241302695 34 193570 1 1
2024-09-13 8-K 8-K 1.01,5.02,7.01,9.01 0000950170-24-106464 001-41052 241298579 34 1515739 1 1
2024-09-13 424B5 PROSPECTUS SUPPLEMENT TO PROSPECTUS DATED FEBRUARY 8, 2023 0001683168-24-006396 333-269494 241298531 33 399921
2024-08-16 1-A xsl1-A_X01/primary_doc.xml 0001683168-24-005833 024-12489 241216895 33 1873471
2024-08-14 10-Q 10-Q 0000950170-24-097056 001-41052 241208291 34 7289288 1 1
2024-08-14 8-K 8-K 2.02,7.01,9.01 0000950170-24-097036 001-41052 241208052 34 330342 1 1
2024-08-13 4 4 0000950170-24-096483 5250
2024-08-13 4 4 0000950170-24-096480 5218
2024-08-13 4 4 0000950170-24-096479 5258
2024-08-13 4 4 0000950170-24-096472 5270
2024-08-13 8-K 8-K 5.02,5.07,9.01 0000950170-24-096305 001-41052 241202068 34 523872 1 1
2024-08-02 8-K 8-K 1.02 0000950170-24-089981 001-41052 241171172 34 154657 1 1
2024-07-09 3 3 0000950170-24-082539 17258
2024-07-03 8-K 8-K 3.01 0000950170-24-081608 001-41052 241100797 34 152549 1 1
2024-06-28 DEFA14A DEFA14A 0000950170-24-079076 001-41052 241086015 34 166068
2024-06-28 ARS ARS 0000950170-24-079073 001-41052 241086002 34 521250
2024-06-28 DEF 14A DEF 14A 0000950170-24-079070 001-41052 241085980 34 1540243
2024-06-18 8-K 8-K 5.02,5.08,7.01,9.01 0000950170-24-074605 001-41052 241050337 34 237236 1 1
2024-05-30 8-K 8-K 1.01,1.02,9.01 0000950170-24-066772 001-41052 241006686 34 227973 1 1
2024-05-22 8-K 8-K 1.01,7.01,9.01 0000950170-24-063295 001-41052 24971737 34 13400325 1 1
2024-05-15 SC 13G SCHEDULE 13G 0001213900-24-043701 005-93529 24952099 34 63574
2024-05-15 10-Q 10-Q 0000950170-24-060534 001-41052 24951539 34 6571542 1 1
2024-05-15 8-K 8-K 2.01,7.01,9.01 0000950170-24-060486 001-41052 24950918 34 300856 1 1
2024-05-13 8-K 8-K 1.01,8.01,9.01 0001193125-24-137269 001-41052 24939626 34 1053967 1 1
2024-05-13 424B4 424B4 0001193125-24-136630 333-278383 24936733 33 1462879
2024-05-09 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-05-09 09:00:00 9999999995-24-001454 333-278383 24932678 33 1788
2024-05-08 CORRESP filename1.htm 0001193125-24-134181 6334
2024-05-08 CORRESP filename1.htm 0001193125-24-134177 6759
2024-05-08 8-K 8-K 8.01,9.01 0000950170-24-055115 001-41052 24924442 34 204447 1 1
2024-05-08 S-1/A S-1/A 0001193125-24-133716 333-278383 24924086 33 8950673 1 1
2024-04-29 S-1/A S-1/A 0001193125-24-119736 333-278383 24886558 33 8399451 1 1
2024-04-08 UPLOAD filename1.pdf 0000000000-24-003732 333-278383 40420
2024-03-29 S-1 S-1 0001193125-24-082079 333-278383 24804303 33 7666122 1 1
2024-03-25 8-K 8-K 2.02,7.01,9.01 0000950170-24-036006 001-41052 24780207 34 291526 1 1
2024-03-25 10-K 10-K 0000950170-24-035946 001-41052 24779565 34 10406794 1 1
2024-03-22 4 4 0000950170-24-035557 4380
2024-03-22 4 4 0000950170-24-035555 5283
2024-03-22 4 4 0000950170-24-035553 5265
2024-02-09 SC 13G/A SCHEDULE 13G/A 0001079973-24-000212 005-93529 24614708 34 29532
2024-02-01 SC 13G/A sc13ga110022tivc_02012024.htm 0000921895-24-000175 005-93529 24585192 34 196276
2024-01-26 8-K 8-K 1.02,5.02 0000950170-24-007968 001-41052 24568319 34 153214 1 1
2023-11-14 10-Q 10-Q 0000950170-23-063771 001-41052 231407040 34 7088866 1 1
2023-11-14 8-K 8-K 2.02,7.01,9.01 0000950170-23-063735 001-41052 231406586 34 383696 1 1
2023-09-26 8-K 8-K 7.01,9.01 0001193125-23-242058 001-41052 231277478 34 178286 1 1
2023-09-20 8-K 8-K 3.01,7.01,9.01 0001193125-23-238127 001-41052 231265403 34 173834 1 1
2023-08-22 8-K 8-K 3.03,5.03,7.01,9.01 0000950170-23-043808 001-41052 231192144 34 281662 1 1
2023-08-14 10-Q 10-Q 0000950170-23-042520 001-41052 231171746 34 7149240 1 1
2023-08-14 8-K 8-K 2.02,5.07,7.01,9.01 0000950170-23-042474 001-41052 231171084 34 463962 1 1
2023-08-09 8-K 8-K 1.01,3.02,8.01,9.01 0000950170-23-040603 001-41052 231155317 34 1153806 1 1
2023-08-08 424B5 424B5 0001193125-23-206265 333-269494 231151911 33 418150
2023-08-04 424B5 424B5 0001193125-23-204017 333-269494 231145014 33 419579
2023-07-31 8-K 8-K 7.01,9.01 0000950170-23-035690 001-41052 231125207 34 215943 1 1
2023-07-28 DEFA14A DEFA14A 0000950170-23-035586 001-41052 231124187 34 55898
2023-07-28 8-K 8-K 3.01,7.01,9.01 0000950170-23-035581 001-41052 231124115 34 239283 1 1
2023-07-24 SC 13G/A SCHEDULE 13G 0001079973-23-001000 005-93529 231105041 34 33417
2023-07-24 DEF 14A DEF 14A 0001193125-23-191774 001-41052 231103653 34 580975
2023-07-19 8-K 8-K 1.01,3.02,8.01,9.01 0000950170-23-033516 001-41052 231096796 34 1151391 1 1
2023-07-17 SC 13G SCHEDULE 13G 0001079973-23-000975 005-93529 231092397 34 32065
2023-07-17 424B5 424B5 0001193125-23-188119 333-269494 231091776 33 411351
2023-07-14 424B5 424B5 0001193125-23-187253 333-269494 231089123 33 432252
2023-07-13 PRE 14A PRE 14A 0001193125-23-186637 001-41052 231087435 34 680195
2023-07-11 8-K 8-K 1.01,3.02,8.01,9.01 0000950170-23-032518 001-41052 231082451 34 1158007 1 1
2023-07-11 424B5 424B5 0001193125-23-185037 333-269494 231081237 33 407538
2023-07-07 424B5 424B5 0001193125-23-183829 333-269494 231077159 33 426448
2023-07-06 8-K 8-K 5.03,9.01 0000950170-23-032062 001-41052 231074382 34 252400 1 1
2023-06-16 4 FORM 4 SUBMISSION 0000899243-23-015786 5393
2023-06-16 4 FORM 4 SUBMISSION 0000899243-23-015785 5381
2023-06-16 4 FORM 4 SUBMISSION 0000899243-23-015784 5337
2023-06-16 8-K 8-K 5.07,8.01 0000950170-23-028676 001-41052 231022144 34 218643 1 1
2023-06-09 DEFA14A DEFA14A 0001193125-23-164563 001-41052 231006330 34 15469
2023-06-09 8-K 8-K 5.07,7.01,9.01 0000950170-23-027305 001-41052 231006275 34 232278 1 1
2023-05-15 10-Q 10-Q 0000950170-23-022256 001-41052 23923244 34 6185198 1 1
2023-05-15 8-K 8-K 2.02,7.01,9.01 0000950170-23-022236 001-41052 23922878 34 394905 1 1
2023-05-10 3 FORM 3 SUBMISSION 0000899243-23-012579 6895
2023-05-10 4 FORM 4 SUBMISSION 0000899243-23-012535 5379
2023-05-10 4 FORM 4 SUBMISSION 0000899243-23-012534 5389
2023-05-10 4 FORM 4 SUBMISSION 0000899243-23-012533 5396
2023-05-01 8-K 8-K 1.02,5.02,7.01,9.01 0000950170-23-016054 001-41052 23870639 34 238420 1 1
2023-04-24 DEFA14A DEFA14A 0001193125-23-113063 001-41052 23840904 34 103616
2023-04-24 DEF 14A DEF 14A 0001193125-23-113056 001-41052 23840877 34 1037496
2023-04-14 PRE 14A PRE 14A 0001193125-23-102238 001-41052 23821906 34 1037930
2023-04-13 8-K 8-K 7.01,9.01 0000950170-23-012626 001-41052 23817192 34 248478 1 1
2023-04-11 8-K 8-K 7.01,9.01 0000950170-23-012374 001-41052 23812466 34 217718 1 1
2023-03-31 10-K 10-K 0000950170-23-011359 001-41052 23787442 34 12772012 1 1
2023-03-31 8-K 8-K 2.02,7.01,9.01 0000950170-23-011178 001-41052 23783614 34 15102963 1 1
2023-02-21 SC 13G sc13g10022tivc_02212023.htm 0000921895-23-000587 005-93529 23648688 34 217555
2023-02-14 5 FORM 5 SUBMISSION 0000899243-23-005056 5258
2023-02-13 8-K 8-K 1.01,8.01,9.01 0000950170-23-002621 001-41052 23618992 34 1264336 1 1
2023-02-10 424B4 424B4 0001193125-23-032652 333-268010 23612365 33 3150128
2023-02-09 POS EX POS EX 0001193125-23-030142 333-268010 23606767 33 68001
2023-02-08 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2023-02-08 17:30:00 9999999995-23-000319 333-268010 23600929 33 1716
2023-02-08 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-02-08 17:00:00 9999999995-23-000330 333-269494 23600920 33 1716
2023-02-06 CORRESP filename1.htm 0001193125-23-025775 9447
2023-02-06 CORRESP filename1.htm 0001193125-23-025771 6861
2023-02-06 CORRESP filename1.htm 0001193125-23-025751 7579
2023-02-06 CORRESP filename1.htm 0001193125-23-025700 7114
2023-02-06 UPLOAD filename1.pdf 0000000000-23-001208 40146
2023-02-02 DEL AM DEL AM 0001193125-23-022658 333-269494 23580477 33 6355
2023-02-01 S-1/A FORM S-1/A 0001193125-23-021594 333-268010 23577088 33 3694848
2023-02-01 S-3 S-3 0001193125-23-020911 333-269494 23574888 33 753470
2023-01-27 8-K 8-K 3.01 0000950170-23-001316 001-41052 23563984 34 173530 1 1
2023-01-25 CORRESP filename1.htm 0001193125-23-015156 7499
2023-01-24 CORRESP filename1.htm 0001193125-23-014259 6593
2023-01-18 CORRESP filename1.htm 0001193125-23-010218 7150
2023-01-17 CORRESP filename1.htm 0001193125-23-009410 6593
2023-01-12 CORRESP filename1.htm 0001193125-23-007289 6953
2023-01-11 CORRESP filename1.htm 0001193125-23-006536 6901
2023-01-10 CORRESP filename1.htm 0001193125-23-005711 6410
2023-01-06 CORRESP filename1.htm 0001193125-23-003636 7371
2023-01-06 CORRESP filename1.htm 0001193125-23-003635 7195
2023-01-06 S-1/A FORM S-1/A 0001193125-23-003081 333-268010 23513887 33 3627143
2022-12-21 8-K 8-K 7.01,9.01 0001193125-22-310154 001-41052 221479065 34 10807522 1 1
2022-12-20 S-1/A FORM S-1/A 0001193125-22-309223 333-268010 221475808 33 3835011
2022-12-09 S-1/A FORM S-1/A 0001193125-22-301436 333-268010 221453716 33 13310130 1 1
2022-12-09 8-K 8-K 1.02,7.01,9.01 0000950170-22-026261 001-41052 221453693 34 215000 1 1
2022-12-01 8-K 8-K 1.01,7.01,9.01 0000950170-22-025922 001-41052 221437460 34 349368 1 1
2022-11-14 10-Q 10-Q 0000950170-22-025033 001-41052 221387632 34 7258698 1 1
2022-11-14 8-K 8-K 2.02,7.01,9.01 0000950170-22-024737 001-41052 221380613 34 526781 1 1
2022-11-02 UPLOAD filename1.pdf 0000000000-22-011938 40264
2022-10-26 8-K 8-K 7.01,9.01 0001193125-22-269556 001-41052 221333242 34 10627209 1 1
2022-10-26 S-1 FORM S-1 0001193125-22-268956 333-268010 221330990 33 14195396 1 1
2022-10-25 8-K 8-K 1.01,9.01 0001193125-22-268361 001-41052 221329541 34 376101 1 1
2022-10-17 8-K 8-K 7.01,9.01 0001193125-22-263392 001-41052 221312609 34 11891112 1 1
2022-10-14 8-K 8-K 1.01,9.01 0001193125-22-262983 001-41052 221311639 34 1016923 1 1
2022-08-15 10-Q 10-Q 0001410578-22-002554 001-41052 221165167 34 4820728 1 1
2022-08-15 8-K 8-K 2.02,7.01,9.01 0001104659-22-090611 001-41052 221162424 34 6404704 1 1
2022-06-21 4/A OWNERSHIP DOCUMENT 0001104659-22-073073 5703
2022-06-21 4/A OWNERSHIP DOCUMENT 0001104659-22-073071 5755
2022-06-21 4/A OWNERSHIP DOCUMENT 0001104659-22-073070 5743
2022-06-17 8-K FORM 8-K 5.07 0001104659-22-072399 001-41052 221024051 34 207237 1 1
2022-06-16 4 OWNERSHIP DOCUMENT 0001104659-22-072045 5336
2022-06-16 4 OWNERSHIP DOCUMENT 0001104659-22-072043 5284
2022-06-16 4 OWNERSHIP DOCUMENT 0001104659-22-072042 5324
2022-05-16 10-Q 10-Q 0001410578-22-001666 001-41052 22929389 34 5428763 1 1
2022-05-16 8-K FORM 8-K 2.02,7.01,9.01 0001104659-22-060870 001-41052 22925582 34 2867314
2022-05-02 DEFA14A DEFA14A 0001140361-22-017252 001-41052 22882076 34 4303075
2022-05-02 DEF 14A DEF 14A 0001140361-22-017248 001-41052 22882008 34 2246163
2022-04-18 8-K FORM 8-K 7.01,9.01 0001104659-22-046946 001-41052 22832809 34 6298331
2022-04-05 4 OWNERSHIP DOCUMENT 0001104659-22-042855 5360
2022-04-05 3 OWNERSHIP DOCUMENT 0001104659-22-042851 2944
2022-04-05 8-K FORM 8-K 1.01,1.02,5.02,7.01,9.01 0001104659-22-042811 001-41052 22807690 34 230631
2022-03-31 10-K FORM 10-K 0001104659-22-041068 001-41052 22792957 34 1085937
2022-02-14 SC 13G SCHEDULE 13G 0001104659-22-022793 005-93529 22631971 34 36323
2022-02-14 SC 13G SCHEDULE 13G 0001104659-22-022745 005-93529 22631898 34 35586
2022-02-08 4 OWNERSHIP DOCUMENT 0001104659-22-014171 5312
2022-02-08 4 OWNERSHIP DOCUMENT 0001104659-22-014166 5323
2022-02-08 4 OWNERSHIP DOCUMENT 0001104659-22-014161 5319
2021-12-22 8-K FORM 8-K 5.02,8.01,9.01 0001104659-21-152721 001-41052 211514112 34 45539
2021-12-16 4 OWNERSHIP DOCUMENT 0001104659-21-150715 5205
2021-12-16 4 OWNERSHIP DOCUMENT 0001104659-21-150714 5299
2021-12-16 4 OWNERSHIP DOCUMENT 0001104659-21-150713 5193
2021-12-16 4 OWNERSHIP DOCUMENT 0001104659-21-150712 5295
2021-12-16 4 OWNERSHIP DOCUMENT 0001104659-21-150711 5153
2021-12-08 8-K FORM 8-K 7.01,9.01 0001104659-21-147453 001-41052 211477760 34 2621413
2021-11-18 8-K FORM 8-K 1.01,7.01 0001104659-21-141304 001-41052 211425633 34 20876
2021-11-17 3 OWNERSHIP DOCUMENT 0001104659-21-140607 13789
2021-11-15 4 OWNERSHIP DOCUMENT 0001104659-21-139507 11491
2021-11-15 8-K FORM 8-K 1.01,5.03,8.01,9.01 0001104659-21-139122 001-41052 211410128 34 599741
2021-11-12 S-8 FORM S-8 0001104659-21-138203 333-261044 211404686 33 85149
2021-11-12 424B4 424B4 0001104659-21-137347 333-258411 211399158 33 2960348
2021-11-10 SEC STAFF LETTER filename1.pdf 9999999997-21-005709 274922
2021-11-10 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-11-10 17:00:00 9999999995-21-004277 333-258411 211398787 33 1695
2021-11-10 3 OWNERSHIP DOCUMENT 0001104659-21-137190 13695
2021-11-10 3 OWNERSHIP DOCUMENT 0001104659-21-137189 14795
2021-11-10 3 OWNERSHIP DOCUMENT 0001104659-21-137188 13043
2021-11-10 3 OWNERSHIP DOCUMENT 0001104659-21-137187 17609
2021-11-10 3 OWNERSHIP DOCUMENT 0001104659-21-137186 13650
2021-11-10 3 OWNERSHIP DOCUMENT 0001104659-21-137185 13080
2021-11-10 3 OWNERSHIP DOCUMENT 0001104659-21-137184 15454
2021-11-10 CERT 8A_Cert_TIVC.pdf 0001354457-21-001319 001-41052 211395825 34 216319
2021-11-10 8-A12B 8-A12B 0001104659-21-136539 001-41052 211394224 34 16175
2021-11-05 CORRESP filename1.htm 0001104659-21-134976 9078
2021-11-05 CORRESP filename1.htm 0001104659-21-134973 24312
2021-10-29 S-1/A S-1/A 0001104659-21-131885 333-258411 211364286 33 3491885
2021-09-23 CORRESP filename1.htm 0001104659-21-118846 25915
2021-09-23 S-1/A FORM S-1/A 0001104659-21-118839 333-258411 211273142 33 2848458
2021-09-20 UPLOAD filename1.pdf 0000000000-21-011364 46216
2021-09-15 SEC STAFF LETTER filename1.pdf 9999999997-21-004799 276164
2021-09-09 S-1/A S-1/A 0001104659-21-114256 333-258411 211245159 33 4949363
2021-09-09 CORRESP filename1.htm 0001104659-21-114250 26638
2021-08-18 UPLOAD filename1.pdf 0000000000-21-010167 43483
2021-08-12 CORRESP filename1.htm 0001104659-21-104101 30559
2021-08-12 S-1/A S-1/A 0001104659-21-104099 333-258411 211167136 33 3084513
2021-08-11 UPLOAD filename1.pdf 0000000000-21-009833 46452
2021-08-03 CORRESP filename1.htm 0001104659-21-099489 30650

Latest XBRL company facts

One latest value per concept from companyfacts (309 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 22.19M 2026-08-13 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
dei EntityPublicFloat Entity Public Float USD 4.00M 2025-06-30 2025 FY 10-K 2026-03-30 0001437749-26-010343
ffd NetFeeAmt NetFeeAmt USD 0 2026-10-13 S-3 2026-10-16 0001683168-26-007936
ffd TtlFeeAmt TtlFeeAmt USD 543.57 2026-10-13 S-3 2026-10-16 0001683168-26-007936
ffd TtlOfferingAmt TtlOfferingAmt USD 6.25M 2026-10-13 S-3 2026-10-16 0001683168-26-007936
ffd TtlOffsetAmt TtlOffsetAmt USD 543.57 2026-10-13 S-3 2026-10-16 0001683168-26-007936
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-09-03 S-3 2026-10-08 0001683168-26-007707
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 639,000 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap AccountsPayableRelatedPartiesCurrent Accounts Payable, Related Parties, Current USD 0 2022-12-31 2022 FY 10-K 2023-03-31 0000950170-23-011359
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 19,000 2025-09-30 2025 Q3 10-Q 2025-11-14 0001437749-25-035216
us-gaap AccruedBonusesCurrent Accrued Bonuses, Current USD 194,000 2025-06-30 2025 Q2 10-Q 2025-08-14 0000950170-25-108977
us-gaap AccruedEmployeeBenefitsCurrent Accrued Employee Benefits, Current USD 321,000 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 143,000 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap AccruedRentCurrent Accrued Rent, Current USD 180,000 2026-03-31 2026 Q1 10-Q 2026-05-14 0001437749-26-017142
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 377,000 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 70.75M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap AdjustmentForAmortization Amortization USD 934,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 133,000 2026-04-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap AdjustmentsToAdditionalPaidInCapitalStockSplit Adjustments to Additional Paid in Capital, Stock Split USD 0 2025-01-01 2025-03-31 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD 0 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0001410578-22-001666
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 375,000 2026-01-01 2026-03-31 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 341,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 0 2025-09-30 2025 Q3 10-Q 2025-11-14 0001437749-25-035216
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 1.75M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-31 0000950170-23-011359
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 40.82M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap AreaOfLand Area of Land sqft 9,091 2024-12-31 2024 FY 10-K 2025-03-21 0000950170-25-043234
us-gaap Assets Assets USD 32.47M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap AssetsCurrent Assets, Current USD 3.38M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 975,000 2025-06-30 2025 Q2 10-Q 2025-08-14 0000950170-25-108977
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Assets, Current USD 0 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap BusinessAcquisitionCostOfAcquiredEntityTransactionCosts Business Acquisition, Transaction Costs USD 243,000 2025-02-11 2025 Q2 10-Q 2025-08-14 0000950170-25-108977
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 2.11M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 975,000 2025-06-30 2025 Q2 10-Q 2025-08-14 0000950170-25-108977
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 2.48M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations USD 0 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 2.48M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -10.17M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 2.20M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations Cash Provided by (Used in) Operating Activities, Discontinued Operations USD 29,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap CashUninsuredAmount Cash, Uninsured Amount USD 2.10M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 14.45 2024-05-31 2025 Q2 10-Q 2025-08-14 0000950170-25-108977
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 61,287 2025-06-30 2025 Q2 10-Q 2025-08-14 0000950170-25-108977
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 8.67M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 42.72M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 200.00M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 4.15M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 4.15M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap CommonStockValue Common Stock, Value, Issued USD 2,000 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 3,000 2025-09-30 2025 Q3 10-Q 2025-11-14 0001437749-25-035216
us-gaap ContractWithCustomerRefundLiability Contract with Customer, Refund Liability USD 5,000 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 1,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-31 0000950170-23-011359
us-gaap ConvertibleDebtNoncurrent Convertible Debt, Noncurrent USD 7.39M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 343,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-14 0001437749-25-035216
us-gaap CostOfRevenue Cost of Revenue USD 52,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0000950170-25-108977
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 1.35M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-31 0000950170-23-011359
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 244,000 2021-01-01 2021-09-30 2022 Q3 10-Q 2022-11-14 0000950170-22-025033
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 631,000 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 12,000 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 112,000 2024-09-30 2024 Q3 10-Q 2024-11-14 0000950170-24-127072
us-gaap DeferredRevenue Deferred Revenue USD 0 2025-06-30 2025 Q2 10-Q 2025-08-14 0000950170-25-108977
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 0 2022-12-31 2022 FY 10-K 2023-03-31 0000950170-23-011359
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 10.25M 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 12,000 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 9.36M 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 333,000 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 215,000 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 10.24M 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap DeferredTaxExpenseFromStockOptionsExercised Deferred Tax Expense from Stock Options Exercised USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-21 0000950170-25-043234
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 0 2024-12-31 2024 FY 10-K 2025-03-21 0000950170-25-043234
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill Deferred Tax Liabilities, Goodwill USD 12,000 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 0 2024-12-31 2024 FY 10-K 2025-03-21 0000950170-25-043234
us-gaap DepositsAssetsCurrent Deposits Assets, Current USD 15,000 2022-09-30 2022 Q3 10-Q 2022-11-14 0000950170-22-025033
us-gaap Depreciation Depreciation USD 362,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 2,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0000950170-25-108977
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD 436,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-31 0000950170-23-011359
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 212,000 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent Disposal Group, Including Discontinued Operation, Assets, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current USD 14,000 2025-12-31 2026 Q1 10-Q 2026-05-14 0001437749-26-017142
us-gaap DividendsCommonStock Dividends, Common Stock USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap DividendsPreferredStock Dividends, Preferred Stock USD 0 2025-07-01 2025-09-30 2025 Q3 10-Q 2025-11-14 0001437749-25-035216
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -4.59 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap EarningsPerShareBasicUndistributed Earnings Per Share, Basic, Undistributed USD/shares -6.54 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-14 0001437749-25-035216
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -4.64 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0000950170-25-108977
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.19 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0000950170-23-011359
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.02 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity Embedded Derivative, No Longer Bifurcated, Amount Reclassified to Stockholders' Equity USD 1.64M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-31 0000950170-23-011359
us-gaap EmployeeBenefitsAndShareBasedCompensationNoncash Employee Benefit and Share-based Payment Arrangement, Noncash USD 90,000 2025-04-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0000950170-25-108977
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 218,000 2023-12-31 2024 FY 10-K 2025-03-21 0000950170-25-043234
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 104,000 2025-06-30 2025 Q2 10-Q 2025-08-14 0000950170-25-108977
us-gaap EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions Share-based Payment Arrangement, Exercise of Option, Tax Benefit USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap FairValueAssetsLevel1ToLevel2TransfersAmount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount USD 0 2022-03-31 2022 Q1 10-Q 2022-05-16 0001410578-22-001666
us-gaap FairValueAssetsLevel2ToLevel1TransfersAmount Fair Value, Assets, Level 2 to Level 1 Transfers, Amount USD 0 2022-03-31 2022 Q1 10-Q 2022-05-16 0001410578-22-001666
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings USD -436,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-31 0000950170-23-011359
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 717,000 2020-12-31 2022 FY 10-K 2023-03-31 0000950170-23-011359
us-gaap GainLossOnContractTermination Gain (Loss) on Contract Termination USD 17,000 2024-01-01 2024-06-30 2025 Q2 10-Q 2025-08-14 0000950170-25-108977
us-gaap GainLossOnDerivativeInstrumentsNetPretax Gain (Loss) on Derivative Instruments, Net, Pretax USD 80,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -117,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-14 0001437749-25-035216
us-gaap GainLossOnTerminationOfLease Gain (Loss) on Termination of Lease USD 60,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-21 0000950170-25-043234
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -1.64M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-31 0000950170-23-011359
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 3.01M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-14 0001437749-25-035216
us-gaap Goodwill Goodwill USD 3.46M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap GrossProfit Gross Profit USD -41,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-14 0001437749-25-035216
us-gaap ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset Impaired Assets to be Disposed of by Method Other than Sale, Carrying Value of Asset USD 117,000 2025-09-30 2025 Q3 10-Q 2025-11-14 0001437749-25-035216
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-14 0001437749-25-035216
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD 8.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -8.24M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-25 0000950170-24-035946
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -13.28M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTax Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -23,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 1.68M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -1.91M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 41,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD -8,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD -189,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 375,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap IncreaseDecreaseInAccountsPayableTrade Increase (Decrease) in Accounts Payable, Trade USD 109,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0000950170-25-108977
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -50,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-14 0001437749-25-035216
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 1.46M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 750,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -242,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet Increase (Decrease) in Other Current Assets and Liabilities, Net USD 2,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0000950170-25-108977
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 90,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 178,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 2.24M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap InterestExpense Interest Expense USD 497,000 2021-01-01 2021-06-30 2022 Q2 10-Q 2022-08-15 0001410578-22-002554
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 1.34M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 7,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0000950170-25-108977
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 77,000 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap InventoryGross Inventory, Gross USD 540,000 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap InventoryNet Inventory, Net USD 750,000 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 458,000 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap InventoryValuationReserves Inventory Valuation Reserves USD 540,000 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 5,000 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap InventoryWriteDown Inventory Write-down USD 230,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-14 0001437749-25-035216
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 35,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 93,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap LeaseCost Lease, Cost USD 1.02M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.06 2024-03-31 2024 Q1 10-Q 2024-05-15 0000950170-24-060534
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 15.57M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 5.96M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.65M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 1.97M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 1.77M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 1.66M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 1.78M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 779,000 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 5.55M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap Liabilities Liabilities USD 20.59M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 32.47M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap LiabilitiesCurrent Liabilities, Current USD 3.05M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Liabilities, Current USD 43,000 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap LineOfCreditFacilityInterestRateDuringPeriod Line of Credit Facility, Interest Rate During Period pure 0.06 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-21 0000950170-25-043234
us-gaap LossContingencyAccrualAtCarryingValue Loss Contingency Accrual USD 0 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap LossContingencyLossInPeriod Loss Contingency, Loss in Period USD 0 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0000950170-25-108977
us-gaap MarketingAndAdvertisingExpense Marketing and Advertising Expense USD 271,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-14 0001437749-25-035216
us-gaap MoneyMarketFundsAtCarryingValue Money Market Funds, at Carrying Value USD 975,000 2025-06-30 2025 Q2 10-Q 2025-08-14 0000950170-25-108977
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 187,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -64,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -10.29M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -10.32M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -13.30M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -3.43M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0000950170-25-108977
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -1.22M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap NumberOfOperatingSegments Number of Operating Segments pure 2 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap NumberOfReportableSegments Number of Reportable Segments pure 2 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap OperatingExpenses Operating Expenses USD 12.06M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -12.06M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap OperatingLeaseCost Operating Lease, Cost USD 916,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 10.02M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 533,000 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 9.49M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap OperatingLeasePayments Operating Lease, Payments USD 375,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001437749-26-017142
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 9.84M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 428,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 33.70M 2024-12-31 2024 FY 10-K 2025-03-21 0000950170-25-043234
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 1.83M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap OtherAssets Other Assets USD 115,000 2022-09-30 2022 Q3 10-Q 2022-11-14 0000950170-22-025033
us-gaap OtherAssetsCurrent Other Assets, Current USD 74,000 2025-06-30 2025 Q2 10-Q 2025-08-14 0000950170-25-108977
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 214,000 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 454,000 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 60,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0000950170-24-127072
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 162,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-31 0000950170-23-011359
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -1,000 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0000950170-22-025033
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 191,000 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 406,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 172,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 68,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-14 0001437749-25-035216
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap PaymentsToAcquireNotesReceivable Payments to Acquire Notes Receivable USD 124,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 64,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap PreferredStockDividendsIncomeStatementImpact Preferred Stock Dividends, Income Statement Impact USD 37,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-14 0001437749-25-035216
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 403 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 403 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap PrepaidExpenseAndOtherAssets Prepaid Expense and Other Assets USD 331,000 2022-09-30 2022 Q3 10-Q 2022-11-14 0000950170-22-025033
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 524,000 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap PrepaidInsurance Prepaid Insurance USD 21,000 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap PrepaidRent Prepaid Rent USD 43,000 2026-03-31 2026 Q1 10-Q 2026-05-14 0001437749-26-017142
us-gaap PrepaidTaxes Prepaid Taxes USD 0 2025-09-30 2025 Q3 10-Q 2025-11-14 0001437749-25-035216
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 2.51M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-31 0000950170-23-011359
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 69,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 585,000 2025-06-25 2025 Q2 10-Q 2025-08-14 0000950170-25-108977
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 100,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-31 0000950170-23-011359
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 56,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-25 0000950170-24-035946
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001437749-26-017142
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -3.43M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0000950170-25-108977
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 12.72M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 12.34M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap ProvisionForOtherCreditLosses Provision for Other Credit Losses USD 5,000 2024-01-01 2024-06-30 2025 Q2 10-Q 2025-08-14 0000950170-25-108977
us-gaap PurchaseCommitmentRemainingMinimumAmountCommitted Purchase Commitment, Remaining Minimum Amount Committed USD 93,000 2022-03-31 2022 Q1 10-Q 2022-05-16 0001410578-22-001666
us-gaap RelatedPartyCosts Related Party Costs USD 5,000 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0001410578-22-001666
us-gaap RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty Related Party Transaction, Expenses from Transactions with Related Party USD 18,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0000950170-23-011359
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 19,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-31 0000950170-23-011359
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 4.56M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 368,000 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -66.51M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 302,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-14 0001437749-25-035216
us-gaap Revenues Revenues USD 156,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0000950170-25-108977
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 277,059 2024-05-01 2024-05-31 2025 Q2 10-Q 2025-08-14 0000950170-25-108977
us-gaap SecurityDeposit Security Deposit USD 16,000 2024-12-31 2024 FY 10-K 2025-03-21 0000950170-25-043234
us-gaap SellingAndMarketingExpense Selling and Marketing Expense USD 1.02M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-14 0001437749-25-035216
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 7.50M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 341,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage pure 0.25 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-21 0000950170-25-043234
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 938 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-25 0000950170-24-035946
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 0.36 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-25 0000950170-24-035946
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 7,500 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0000950170-24-127072
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.34 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0000950170-24-127072
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 3,750 2024-09-30 2024 Q3 10-Q 2024-11-14 0000950170-24-127072
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 1.34 2024-09-30 2024 Q3 10-Q 2024-11-14 0000950170-24-127072
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 3,750 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0000950170-24-127072
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value USD 11,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0000950170-23-011359
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 1.34 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0000950170-24-127072
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 1.193 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-21 0000950170-25-043234
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 1.146 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-21 0000950170-25-043234
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.044 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-21 0000950170-25-043234
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.038 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-21 0000950170-25-043234
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend USD 0.99 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0001410578-22-001666
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 356,002 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 0 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 7,136 2025-09-30 2025 Q3 10-Q 2025-11-14 0001437749-25-035216
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 22.63 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 0 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 81,492 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 16,874 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 45,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 2.82 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value USD/shares 2.79 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 2.96 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 0 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 60,627 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 6.13 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 0 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 16,948 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 114.62 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 8 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 5.86 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period shares 443,750 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0001410578-22-001666
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-21 0000950170-25-043234
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 0.71 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-31 0000950170-23-011359
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 3.22 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 3.12 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 104,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 4.25M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.059 2025-03-01 2025-03-31 2025 Q2 10-Q 2025-08-14 0000950170-25-108977
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 277,059 2024-05-01 2024-05-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap StockIssuedDuringPeriodSharesReverseStockSplits Stock Issued During Period, Shares, Reverse Stock Splits shares 1 2025-03-07 2025 Q2 10-Q 2025-08-14 0000950170-25-108977
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap StockIssuedDuringPeriodSharesStockSplits Stock Issued During Period, Shares, Stock Splits shares 76 2025-03-07 2025 Q2 10-Q 2025-08-14 0000950170-25-108977
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 0 2025-07-01 2025-09-30 2025 Q3 10-Q 2025-11-14 0001437749-25-035216
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 1.91M 2025-04-01 2025-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap StockIssuedDuringPeriodValuePurchaseOfAssets Stock Issued During Period, Value, Purchase of Assets USD 1.70M 2025-01-01 2025-03-31 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 0 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 0 2026-04-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 56,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-25 0000950170-24-035946
us-gaap StockRepurchasedDuringPeriodShares Stock Repurchased During Period, Shares shares 938 2022-04-01 2023 FY 10-K 2024-03-25 0000950170-24-035946
us-gaap Supplies Prepaid Supplies USD 120,000 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap TaxCreditCarryforwardAmount Tax Credit Carryforward, Amount USD 70,000 2024-12-31 2024 FY 10-K 2025-03-21 0000950170-25-043234
us-gaap TaxesPayableCurrent Taxes Payable, Current USD 19,000 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap UndistributedEarningsLossAvailableToCommonShareholdersBasic Undistributed Earnings (Loss) Available to Common Shareholders, Basic USD -13.79M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap UnrealizedGainLossOnDerivatives Unrealized Gain (Loss) on Derivatives USD 436,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-31 0000950170-23-011359
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 115,000 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions USD 17,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-21 0000950170-25-043234
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 7,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 1.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010343
us-gaap WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1 WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1 USD 0 2026-04-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 70,000 2024-05-31 2025 Q2 10-Q 2025-08-14 0000950170-25-108977
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 739,618 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0000950170-25-108977
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 3.00M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001437749-26-028069

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →